Matrix systems for oral drug delivery: Formulations and drug release

Insights, 2017, vol. 2018 Caraballo, 2009, Critical points in the formulation of pharmaceutical swellable controlled release dosage forms — influence of particle size, Particuology, 7, 421, 10.1016/j.partic.2009.10.002 Kuentz, 2016, Methodology of oral formulation selection in the pharmaceutical industry, Eur J Pharm Sci, 87, 136, 10.1016/j.ejps.2015.12.008 Li, 2006, In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets, Int J Pharm, 324, 152, 10.1016/j.ijpharm.2006.06.006 Rodrigues, 2013, The systems containing clays and clay minerals from modified drug release: a review, Colloids Surf B Biointerfaces, 103, 642, 10.1016/j.colsurfb.2012.10.068 Kottala, 2012, Evaluation of the performance characteristics of bilayer tablets: part I. Impact of material properties and process parameters on the strength of bilayer tablets, AAPS PharmSciTech, 13, 1236, 10.1208/s12249-012-9845-9 Lopez, 2016, Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers, Eur J Pharm Sci, 92, 156, 10.1016/j.ejps.2016.07.006 Lewis, 2018, vol. 2018 Dictionary, 2018, vol. 2018 Banker, 1958, The uniformity of distribution of phosphorus compounds in tablet matrices using radioactive tracer techniques, J Am Pharm Assoc Am Pharm Assoc, 47, 628, 10.1002/jps.3030470905 Frenning, 2011, Modelling drug release from inert matrix systems: from moving-boundary to continuous-field descriptions, Int J Pharm, 418, 88, 10.1016/j.ijpharm.2010.11.030 Dictionary, 2018, vol. 2018 Qiu, 2009, Rational design of oral modified-release drug delivery systems, 469 Rosiaux, 2014, Solid lipid excipients – Matrix agents for sustained drug delivery, J. Controlled Release, 188, 18, 10.1016/j.jconrel.2014.06.004 Ofori-Kwakye, 2016, Development and evaluation of natural gum-based extended release matrix tablets of two model drugs of different water solubilities by direct compression, Saudi Pharm J, 24, 82, 10.1016/j.jsps.2015.03.005 Sato, 1997, Dissolution mechanism of diclofenac sodium from wax matrix granules, J Pharm Sci, 86, 929, 10.1021/js960221w Siepmann, 2006, Controlled drug release from Gelucire-based matrix pellets: experiment and theory, Int J Pharm, 317, 136, 10.1016/j.ijpharm.2006.03.006 Martinez, 2017, Matrix tablets based on amino acid-derived polyesteramide containing release modifiers, J Drug Deliv Sci Technol, 42, 307, 10.1016/j.jddst.2017.05.003 Hong Wen, 2010, Introduction and overview of oral controlled release formulation design, 1 Martinez, 2017, Application of a biodegradable polyesteramide derived from l-alanine as novel excipient for controlled release matrix tablets, AAPS PharmSciTech, 18, 3286, 10.1208/s12249-017-0809-y Grund, 2014, The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets, Int J Pharm, 469, 94, 10.1016/j.ijpharm.2014.04.033 Jannin, 2008, Approaches for the development of solid and semi-solid lipid-based formulations, Adv Drug Deliv Rev, 60, 734, 10.1016/j.addr.2007.09.006 Crowley, 2004, Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion, Int J Pharm, 269, 509, 10.1016/j.ijpharm.2003.09.037 Picker, 1998, Tablet formation and release from matrix tablets manufactured with cellulose acetate, Int J Pharm, 175, 147, 10.1016/S0378-5173(98)00271-3 Villanova, 2011, Design of prolonged release tablets using new solid acrylic excipients for direct compression, Eur J Pharm Biopharm, 79, 664, 10.1016/j.ejpb.2011.07.011 Campinez, 2015, A new biodegradable polythiourethane as controlled release matrix polymer, Int J Pharm, 480, 63, 10.1016/j.ijpharm.2015.01.011 Rosiaux, 2014, Solid lipid excipients — matrix agents for sustained drug delivery, J Control Release, 188, 18, 10.1016/j.jconrel.2014.06.004 Feeney, 2016, 50 years of oral lipid-based formulations: provenance, progress and future perspectives, Adv Drug Deliv Rev, 101, 167, 10.1016/j.addr.2016.04.007 Cifuentes, 2013, Critical points in ethylcellulose matrices: influence of the polymer, drug and filler properties, Acta Pharm, 63, 115, 10.2478/acph-2013-0005 Vithani, 2013, Sustained release solid lipid matrices processed by hot-melt extrusion (HME), Colloids Surf B Biointerfaces, 110, 403, 10.1016/j.colsurfb.2013.03.060 Miyagawa, 1996, Controlled-release of diclofenac sodium from wax matrix granule, Int J Pharm, 138, 215, 10.1016/0378-5173(96)04547-4 Jannin, 2006, Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5, Int J Pharm, 309, 6, 10.1016/j.ijpharm.2005.10.042 Leuenberger, 1987, Percolation theory — a novel-approach to solid dosage form design, Int J Pharm, 38, 109, 10.1016/0378-5173(87)90105-0 Aguilar-de-Leyva, 2011, Release behaviour of clozapine matrix pellets based on percolation theory, Int J Pharm, 404, 133, 10.1016/j.ijpharm.2010.11.024 FernandezHervas, 1996, Using the percolation theory to explain the release behavior from inert matrix systems, Drug Dev Ind Pharm, 22, 201, 10.3109/03639049609058562 Maderuelo, 2011, Critical factors in the release of drugs from sustained release hydrophilic matrices, J Control Release, 154, 2, 10.1016/j.jconrel.2011.04.002 Li, 2015, Applications of natural polymeric materials in solid oral modified-release dosage forms, Curr Pharm Des, 21, 5854, 10.2174/1381612821666151008150306 Gallardo, 2008, Controlled release solid dosage forms using combinations of (meth)acrylate copolymers, Pharm Dev Technol, 13, 413, 10.1080/10837450802202098 Siepmann, 2012, Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC), Adv Drug Deliv Rev, 64, 163, 10.1016/j.addr.2012.09.028 Colombo, 1995, Drug diffusion front movement is important in drug-release control from swellable matrix tablets, J Pharm Sci, 84, 991, 10.1002/jps.2600840816 Kaunisto, 2011, Mechanistic modelling of drug release from polymer-coated and swelling and dissolving polymer matrix systems, Int J Pharm, 418, 54, 10.1016/j.ijpharm.2011.01.021 Gao, 1996, Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release, J Pharm Sci, 85, 732, 10.1021/js9504595 Colombo, 1990, Drug release modulation by physical restrictions of matrix swelling, Int J Pharm, 63, 43, 10.1016/0378-5173(90)90099-P Chen, 2016, Mathematical model-based accelerated development of extended-release metformin hydrochloride tablet formulation, AAPS PharmSciTech, 17, 1007, 10.1208/s12249-015-0423-9 Sadia, 2018, Channelled tablets: an innovative approach to accelerating drug release from 3D printed tablets, J Control Release, 269, 355, 10.1016/j.jconrel.2017.11.022 Hollander, 2017, 3D printed UV light cured polydimethylsiloxane devices for drug delivery, Int J Pharm Jonathan, 2016, 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems, Int J Pharm, 499, 376 Yang, 2018, 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release, Eur J Pharm Sci, 115, 11, 10.1016/j.ejps.2018.01.005 Katstra, 2000, Oral dosage forms fabricated by three dimensional printing, J Control Release, 66, 1, 10.1016/S0168-3659(99)00225-4 Yu, 2007, Tablets with material gradients fabricated by three-dimensional printing, J Pharm Sci, 96, 2446, 10.1002/jps.20864 Martinez, 2017, Fabrication of drug-loaded hydrogels with stereolithographic 3D printing, Int J Pharm, 532, 313, 10.1016/j.ijpharm.2017.09.003 Wang, 2016, Stereolithographic (SLA) 3D printing of oral modified-release dosage forms, Int J Pharm, 503, 207, 10.1016/j.ijpharm.2016.03.016 Palo, 2017, 3D printed drug delivery devices: perspectives and technical challenges, Expert Rev Med Devices, 14, 685, 10.1080/17434440.2017.1363647 Pereira, 2015, 3D photo-fabrication for tissue engineering and drug delivery, Engineering, 1, 90, 10.15302/J-ENG-2015015 Norman, 2017, A new chapter in pharmaceutical manufacturing: 3D-printed drug products, Adv Drug Deliv Rev, 108, 39, 10.1016/j.addr.2016.03.001 Arcaute, 2010, Stereolithography of spatially controlled multi-material bioactive poly(ethylene glycol) scaffolds, Acta Biomater, 6, 1047, 10.1016/j.actbio.2009.08.017 Masters, 2005, Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells, Biomaterials, 26, 2517, 10.1016/j.biomaterials.2004.07.018 Kim, 2009, Visible light induced dextran-methacrylate hydrogel formation using (-)-riboflavin vitamin B2 as a photoinitiator and l-arginine as a co-initiator, Fibers Polym, 10, 14, 10.1007/s12221-009-0014-z Fricke, 1988, Aerogels — highly tenuous solids with fascinating properties, J Non Cryst Solids, 100, 169, 10.1016/0022-3093(88)90014-2 Soleimani Dorcheh, 2008, Silica aerogel; synthesis, properties and characterization, J Mater Process Technol, 199, 10, 10.1016/j.jmatprotec.2007.10.060 Berg A., Droege M., Fellmann J., Klaveness J., Rongved P. Medical use of organic aerogels and biodegradable organic aerogels. WO Patent WO1995001165; 1995. 95. p. 01165. Schwertfeger F, Zimmermann A, Krempel H. Use of inorganic aerogels in pharmacy; 2001, US Patent US6280744 B1. Ulker, 2014, An emerging platform for drug delivery: aerogel based systems, J Control Release, 177, 51, 10.1016/j.jconrel.2013.12.033 Smirnova, 2003, Adsorption of drugs on silica aerogels, Langmuir, 19, 8521, 10.1021/la0345587 Gorle, 2010, Adsorptive crystallization of benzoic acid in aerogels from supercritical solutions, J Supercrit Fluids, 52, 249, 10.1016/j.supflu.2010.01.006 Smirnova, 2005, Aerogels: tailor-made carriers for immediate and prolonged drug release, KONA Powder Part J, 23, 86, 10.14356/kona.2005012 Gorle, 2008, Crystallization under supercritical conditions in aerogels, J Supercrit Fluids, 44, 78, 10.1016/j.supflu.2007.08.004 Alnaief, 2010, Effect of surface functionalization of silica aerogel on their adsorptive and release properties, J Non Cryst Solids, 356, 1644, 10.1016/j.jnoncrysol.2010.06.027 Guenther, 2008, Hydrophilic silica aerogels as dermal drug delivery systems — dithranol as a model drug, Eur J Pharm Biopharm, 69, 935, 10.1016/j.ejpb.2008.02.003 Murillo-Cremaes, 2013, Nanostructured silica-based drug delivery vehicles for hydrophobic and moisture sensitive drugs, J Supercrit Fluids, 73, 34, 10.1016/j.supflu.2012.11.006 Smirnova, 2004, Feasibility study of hydrophilic and hydrophobic silica aerogels as drug delivery systems, J Non Cryst Solids, 350, 54, 10.1016/j.jnoncrysol.2004.06.031 Gurikov, 2018, Amorphization of drugs by adsorptive precipitation from supercritical solutions: a review, J Supercrit Fluids, 132, 105, 10.1016/j.supflu.2017.03.005 Zhao, 2018, Biopolymer aerogels: chemistry, properties and applications, Angew Chem García-González, 2015, Polysaccharide-based aerogel microspheres for oral drug delivery, Carbohydr Polym, 117, 797, 10.1016/j.carbpol.2014.10.045 Mehling, 2009, Polysaccharide-based aerogels as drug carriers, J Non Cryst Solids, 355, 2472, 10.1016/j.jnoncrysol.2009.08.038 García-González, 2011, Polysaccharide-based aerogels — promising biodegradable carriers for drug delivery systems, Carbohydr Polym, 86, 1425, 10.1016/j.carbpol.2011.06.066 Veronovski, 2013, Preparation of multi-membrane alginate aerogels used for drug delivery, J Supercrit Fluids, 79, 209, 10.1016/j.supflu.2013.01.025 García-González, 2013, Use of supercritical fluid technology for the production of tailor-made aerogel particles for delivery systems, J Supercrit Fluids, 79, 152, 10.1016/j.supflu.2013.03.001 Veronovski, 2012, Synthesis and use of organic biodegradable aerogels as drug carriers, J Biomater Sci Polym Ed, 23, 873, 10.1163/092050611X566126 Veronovski, 2014, Characterisation of biodegradable pectin aerogels and their potential use as drug carriers, Carbohydr Polym, 113, 272, 10.1016/j.carbpol.2014.06.054 Veres, 2017, Mechanism of drug release from silica-gelatin aerogel—relationship between matrix structure and release kinetics, Colloids Surf B: Biointerfaces, 152, 229, 10.1016/j.colsurfb.2017.01.019 Ayers, 2001, Synthesis and properties of chitosan–silica hybrid aerogels, J Non Cryst Solids, 285, 123, 10.1016/S0022-3093(01)00442-2 Hoffmann, 2006, Silica-based mesoporous organic–inorganic hybrid materials, Angew Chem Int Ed, 45, 3216, 10.1002/anie.200503075 Fagundes, 2006, SBA-15-collagen hybrid material for drug delivery applications, J Non Cryst Solids, 352, 3496, 10.1016/j.jnoncrysol.2006.03.111 Martins, 2015, Preparation of macroporous alginate-based aerogels for biomedical applications, J Supercrit Fluids, 106, 152, 10.1016/j.supflu.2015.05.010 Quraishi, 2015, Novel non-cytotoxic alginate–lignin hybrid aerogels as scaffolds for tissue engineering, J Supercrit Fluids, 105, 1, 10.1016/j.supflu.2014.12.026 Raman, 2015, Hybrid alginate based aerogels by carbon dioxide induced gelation: novel technique for multiple applications, J Supercrit Fluids, 106, 23, 10.1016/j.supflu.2015.05.003 Veres, 2015, Hybrid aerogel preparations as drug delivery matrices for low water-solubility drugs, Int J Pharm, 496, 360, 10.1016/j.ijpharm.2015.10.045 Goncalves, 2016, Alginate-based hybrid aerogel microparticles for mucosal drug delivery, Eur J Pharm Biopharm, 107, 160, 10.1016/j.ejpb.2016.07.003 Veres, 2017, Biocompatible silica-gelatin hybrid aerogels covalently labeled with fluorescein, J Non Cryst Solids, 473, 17, 10.1016/j.jnoncrysol.2017.07.016 Guenther, 2008, Hydrophilic silica aerogels as dermal drug delivery systems — dithranol as a model drug, Eur J Pharm Biopharm, 69, 935, 10.1016/j.ejpb.2008.02.003 Veres, 2015, Hybrid aerogel preparations as drug delivery matrices for low water-solubility drugs, Int J Pharm, 496, 360, 10.1016/j.ijpharm.2015.10.045 Murillo-Cremaes, 2013, Nanostructured silica-based drug delivery vehicles for hydrophobic and moisture sensitive drugs, J Supercrit Fluids, 73, 34, 10.1016/j.supflu.2012.11.006 Oliveira, 2011, Assembled modules technology for site-specific prolonged delivery of norfloxacin, Int J Pharm, 405, 90, 10.1016/j.ijpharm.2010.11.050 Kuentz, 2016, Methodology of oral formulation selection in the pharmaceutical industry, Eur J Pharm Sci, 87, 136, 10.1016/j.ejps.2015.12.008 Qi, 2015, Floating tablets for controlled release of ofloxacin via compression coating of hydroxypropyl cellulose combined with effervescent agent, Int J Pharm, 489, 210, 10.1016/j.ijpharm.2015.05.007 Elzayat, 2017, Formulation and pharmacokinetics of multi-layered matrix tablets: biphasic delivery of diclofenac, Saudi Pharm J, 25, 688, 10.1016/j.jsps.2016.10.004 Tao, 2017, Understanding the delamination risk of a trilayer tablet using minipiloting tools, J Pharm Sci, 106, 3346, 10.1016/j.xphs.2017.07.005 Stegemann, 2002, Hard gelatin capsules today and tomorrow, Capsugel, 1 Cole, 2008, Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration, Adv Drug Deliv Rev, 60, 747, 10.1016/j.addr.2007.09.009 Nair, 2004, Investigation of various factors affecting encapsulation on the in-cap automatic capsule-filling machine, AAPS PharmSciTech, 5, 10.1208/pt050457 Nguyen, 2008, Formulation of sustained-release verapamil HCl and diltiazem HCl semisolid matrix capsules, Pharm Dev Technol, 13, 115, 10.1080/10837450701831070 Karanth, 2006, Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report, AAPS PharmSciTech, 7, 10.1208/pt070487 Serajuddin, 1999, Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs, J Pharm Sci, 88, 1058, 10.1021/js980403l Goole, 2008, Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa, Int J Pharm, 364, 54, 10.1016/j.ijpharm.2008.08.016 Mazer, 1988, Intragastric behavior and absorption kinetics of a normal and “floating” modified-release capsule of isradipine under fasted and fed conditions, J Pharm Sci, 77, 647, 10.1002/jps.2600770802 Crowley, 2007, Pharmaceutical applications of hot-melt extrusion: part I, Drug Dev Ind Pharm, 33, 909, 10.1080/03639040701498759 Repka, 2007, Pharmaceutical applications of hot-melt extrusion: part II, Drug Dev Ind Pharm, 33, 1043, 10.1080/03639040701525627 Balogh, 2017, Controlled-release solid dispersions of Eudragit (R) FS 100 and poorly soluble spironolactone prepared by electrospinning and melt extrusion, Eur Polym J, 95, 406, 10.1016/j.eurpolymj.2017.08.032 Puri, 2017, Development of maltodextrin-based immediate-release tablets using an integrated twin-screw hot-melt extrusion and injection-molding continuous manufacturing process, J Pharm Sci, 106, 3328, 10.1016/j.xphs.2017.06.020 Singh, 2016, Spray drying formulation of amorphous solid dispersions, Adv Drug Deliv Rev, 100, 27, 10.1016/j.addr.2015.12.010 Davis, 2018, Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs, J Control Release, 269, 110, 10.1016/j.jconrel.2017.11.005 Arpagaus, 2018, Nano spray drying for encapsulation of pharmaceuticals, Int J Pharm, 546, 194, 10.1016/j.ijpharm.2018.05.037 Sosnik, 2015, Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers, Adv Colloid Interface Sci, 223, 40, 10.1016/j.cis.2015.05.003 Ishwarya, 2015, Spray-freeze-drying: a novel process for the drying of foods and bioproducts, Trends Food Sci Technol, 41, 161, 10.1016/j.tifs.2014.10.008 Wanning, 2015, Pharmaceutical spray freeze drying, Int J Pharm, 488, 136, 10.1016/j.ijpharm.2015.04.053 Thakkar, 2017, Electrospun polymeric nanofibers: new horizons in drug delivery, Eur J Pharm Sci, 107, 148, 10.1016/j.ejps.2017.07.001 Chou, 2015, Current strategies for sustaining drug release from electrospun nanofibers, J Control Release, 220, 584, 10.1016/j.jconrel.2015.09.008 Rutledge, 2007, Formation of fibers by electrospinning, Adv Drug Deliv Rev, 59, 1384, 10.1016/j.addr.2007.04.020 Blakney, 2013, Electrospun fibers for vaginal anti-HIV drug delivery, Antiviral Res, 100, S9, 10.1016/j.antiviral.2013.09.022 Meinel, 2012, Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications, Eur J Pharm Biopharm, 81, 1, 10.1016/j.ejpb.2012.01.016 Celebioglu, 2011, Electrospinning of polymer-free nanofibers from cyclodextrin inclusion complexes, Langmuir, 27, 6218, 10.1021/la1050223 Li, 2013, Electrospun polyvinyl-alcohol nanofibers as oral fast-dissolving delivery system of caffeine and riboflavin, Colloids Surf B Biointerfaces, 103, 182, 10.1016/j.colsurfb.2012.10.016 Yu, 2009, Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers, Nanotechnology, 20, 10.1088/0957-4484/20/5/055104 Szabo, 2014, Preformulation study of fiber formation and formulation of drug-loaded microfiber based orodispersible tablets for in vitro dissolution enhancement, Int J Pharm, 477, 643, 10.1016/j.ijpharm.2014.11.011 Teskac, 2010, The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol, Int J Pharm, 390, 61, 10.1016/j.ijpharm.2009.10.011 Kuo, 2013, Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia, Colloids Surf B Biointerfaces, 101, 101, 10.1016/j.colsurfb.2012.06.002 Geszke-Moritz, 2016, Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies, Mater Sci Eng C Mater Biol Appl, 68, 982, 10.1016/j.msec.2016.05.119 Lai, 2014, Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate, Colloids Surf B Biointerfaces, 118, 154, 10.1016/j.colsurfb.2014.03.017 Han, 2016, Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading, Front Pharmacol, 7, 10.3389/fphar.2016.00185 Zhang, 2014, PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications, J Control Release, 183, 77, 10.1016/j.jconrel.2014.03.026 Jasinska-Stroschein, 2017, Statistical considerations concerning dissimilar regulatory requirements for dissolution similarity assessment. The example of immediate-release dosage forms, J Pharm Sci, 106, 1275, 10.1016/j.xphs.2017.01.003 Sengupta, 2018, Current regulatory requirements and practical approaches for stability analysis of pharmaceutical products: a comprehensive review, Int J Pharm, 543, 328, 10.1016/j.ijpharm.2018.04.007 Khan, 1996, Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: challenges and opportunities, Int J Pharm, 140, 131, 10.1016/0378-5173(96)04561-9 Gupta, 2006, Review of global regulations concerning biowaivers for immediate release solid oral dosage forms, Eur J Pharm Sci, 29, 315, 10.1016/j.ejps.2006.05.001 Qiu Y., Chen Y., Zhang G.G.Z., Yu L.X., Mantri R.V. Developing solid oral dosage forms: pharmaceutical theory & practice. Second edition. ed. xiv, 1160 pages. Crean, 2010, Elucidation of the internal physical and chemical microstructure of pharmaceutical granules using X-ray micro-computed tomography, Raman microscopy and infrared spectroscopy, Eur J Pharm Biopharm, 76, 498, 10.1016/j.ejpb.2010.08.006 Akseli, 2011, A quantitative correlation of the effect of density distributions in roller-compacted ribbons on the mechanical properties of tablets using ultrasonics and X-ray tomography, AAPS PharmSciTech, 12, 834, 10.1208/s12249-011-9640-z Yaghmur, 2009, Characterization and potential applications of nanostructured aqueous dispersions, Adv Colloid Interface Sci, 147–148, 333, 10.1016/j.cis.2008.07.007 Watanabe, 2018, Stability and drug release studies of an antimycotic nanomedicine using HPLC, dynamic light scattering and atomic force microscopy, J Pharm Biomed Anal, 148, 149, 10.1016/j.jpba.2017.09.030 Edwardson, 2004, Atomic force microscopy and drug discovery, Drug Discov Today, 9, 64, 10.1016/S1359-6446(03)02905-2 Katona, 2016, Formulation of paracetamol-containing pastilles with in situ coating technology, Eur J Pharm Sci, 95, 54, 10.1016/j.ejps.2016.08.006 Maniruzzaman, 2014, Prediction of polymorphic transformations of paracetamol in solid dispersions, J Pharm Sci, 103, 1819, 10.1002/jps.23992 Zimmermann, 2011, Thermal analysis of paracetamol polymorphs by FT-IR spectroscopies, J Pharm Biomed Anal, 54, 295, 10.1016/j.jpba.2010.08.023 Choy, 2005, Significance of lipid matrix aging on in vitro release and in vivo bioavailability, Int J Pharm, 299, 55, 10.1016/j.ijpharm.2005.04.030 Maniruzzaman, 2016, Novel controlled release polymer-lipid formulations processed by hot melt extrusion, AAPS PharmSciTech, 17, 191, 10.1208/s12249-015-0470-2 Bartolomei, 2007, Hydrate modifications of the non-steroidal anti-inflammatory drug diclofenac sodium: solid-state characterisation of a trihydrate form, J Pharm Biomed Anal, 45, 443, 10.1016/j.jpba.2007.07.002 Fini, 2010, Diclofenac salts. V. Examples of polymorphism among diclofenac salts with alkyl-hydroxy amines studied by DSC and HSM, Pharmaceutics, 2, 136, 10.3390/pharmaceutics2020136 Ali, 2017, Ammonio methacrylate copolymer as a carrier for water-insoluble drug, preparation and characterization of an oral controlled-release matrix tablet, J Drug Deliv Sci Technol, 41, 7, 10.1016/j.jddst.2017.06.016 Wang, 2011, Polymorph transformation in paracetamol monitored by In-line NIR spectroscopy during a cooling crystallization process, AAPS PharmSciTech, 12, 764, 10.1208/s12249-011-9642-x da Silva, 2015, Quantitative analysis of mebendazole polymorphs in pharmaceutical raw materials using near-infrared spectroscopy, J Pharm Biomed Anal, 115, 587, 10.1016/j.jpba.2015.08.018 Kazsoki, 2017, Macro- and microstructural tracking of ageing-related changes of papaverine hydrochloride-loaded electrospun nanofibrous buccal sheets, J Pharm Biomed Anal, 143, 62, 10.1016/j.jpba.2017.05.035 Kumar, 2008, Studies of the o-Ps lifetime and free volume in ion irradiated Makrofol-KG polycarbonate by positron annihilation, Radiat Meas, 43, S578, 10.1016/j.radmeas.2008.04.059 Huang, 2012, Investigation of fine-structure of polyamide thin-film composite membrane under swelling effect by positron annihilation lifetime spectroscopy and molecular dynamics simulation, J Membr Sci, 417, 201, 10.1016/j.memsci.2012.06.036 Hegyesi, 2014, Characterization of ethylcellulose free films by positron annihilation spectroscopy and mechanical testing, Microchem J, 115, 47, 10.1016/j.microc.2014.02.007 Alcala, 2010, On-line monitoring of a granulation process by NIR spectroscopy, J Pharm Sci, 99, 336, 10.1002/jps.21818 Dave, 2017, Emerging technologies for the non-invasive characterization of physical-mechanical properties of tablets, Int J Pharm, 532, 299, 10.1016/j.ijpharm.2017.09.009 Hansuld, 2014, A review of monitoring methods for pharmaceutical wet granulation, Int J Pharm, 472, 192, 10.1016/j.ijpharm.2014.06.027